![Frédéric Lemaître-Auger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frédéric Lemaître-Auger
Directeur/Membre du Conseil chez Encycle Therapeutics, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jeffrey A. M. Coull | M | - |
Encycle Therapeutics, Inc.
![]() Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | 11 ans |
Laurence Rulleau | M | - |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | - |
Andrei Yudin | M | - |
Encycle Therapeutics, Inc.
![]() Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | - |
Paul Truex | M | 55 |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | - |
Kevin Koch | M | 63 |
Encycle Therapeutics, Inc.
![]() Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | - |
William C. Mills | M | 68 |
Encycle Therapeutics, Inc.
![]() Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | - |
Philippe Douville | M | 62 |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | 2 ans |
Pascal Neuville | M | 60 |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | - |
Raf Hofstein | M | 74 |
Encycle Therapeutics, Inc.
![]() Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | - |
Youssef Bennani | M | 63 |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | - |
Marjorie Sidhoum | M | - |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Canada | 11 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Frédéric Lemaître-Auger
- Réseau Personnel